Searchable abstracts of presentations at key conferences in endocrinology

ea0070ep263 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Managing pregnancy in a diabetic patient with chronic kidney disease at the hemodialysis stage: An unresolved case

Jemai Chaima , Kandara Hajer

Introduction: Pregnancy in case diabetes complicated by chronic renal failure is characterized by a very high maternal and fetal risk.Method: We report the case of a patient with diabetes and chronic renal failure at the hemodialysis stage who wishes to lead a pregnancy despite all the risks involved and of which she had been informed beforehand.Results: This is a 39-year-old patient, with type 1 diabetes for 26 years. Her diabetes...

ea0070ep331 | Pituitary and Neuroendocrinology | ECE2020

GH deficiency in children with sickle cell anemia: About a case

Dorraelguiche Dorra , Jemel Manel , Anis Grassa , Kandara Hajer , Kammoun Ines

Introduction: Growth retardation in sickle cell children is common and multifactorial. Recent evidence suggests damage to the somatotropic axis. We report the case of a patient followed for homozygous sickle cell anemia and in whom we discover an associated GH deficiency.Observation: It is a 13 year old child followed for homozygous sickle cell anemia, splenectomized for 2 years, not polytransfused. We were sent to the hematology department before a dela...

ea0070ep333 | Pituitary and Neuroendocrinology | ECE2020

Pituitary metastasis from lung cancer: uncomon presentation

Anis Grassa , Jemel Manel , Salma Salhi , Kandara Hajer , Kammoun Ines

Background: Pituitary gland metastasis is rarely the initial presentation of metastatic cancer. Most cases of pituitary gland metastasis are asymptomatic with diabetes insipidus being the most common symptomatic presentation. It can rarely present with symptoms of hormone underproduction such as anterior pituitary deficiency. Although pituitary gland metastasis is rare, it is underestimated, as it is commonly misdiagnosed with pituitary gland adenoma due to the lack of clear r...

ea0099p295 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Eating disorders in obese patients with type 2 diabetes

Adel Meriem , Chiboub Marwa , Zelaiti Asma , Kandara Hajer , Kammoun Ines

Introduction: Eating disorders (ED) are more prevalent among obese individuals with type 2 diabetes than in the general population. The co-occurrence of diabetes and ED can impair metabolic control, resulting in earlier and more severe degenerative complications, as well as increased morbidity and mortality. This study aims to assess the prevalence of eating disorders in obese patients with type 2 diabetes.Method: A cross-sectional descriptive study was ...

ea0081ep340 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

COVID-19 pandemic: Impact on follow up care of insulin-requiring diabetic patients

Kardi Asma , Gharbi Radhouen , Salem Maram Ben , Jemel Manel , Kandara Hajer , Chiboub Marwa , Kammoun Ines

Introduction: COVID-19 is a novel pandemic affecting globally. It has led to an unprecedented global health crisis assessing health system’s preparedness to deal with health disasters. The aim of our study was to evaluate the impact of COVID-19 on the follow up care of diabetic patients.Methods: We conducted a retrospective study in 100 insulin-requiring diabetic patients. Data regarding treatment availability, weigh, glycemic control and follow up ...

ea0081ep466 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Insulin analogs: do patients know their treatment advantages and modalities?

Bornaz Emna , Gharbi Radhouen , Ghram Lina , Chiboub Marwa , Kandara Hajer , Jemel Manel , Kammoun Ines

Introduction: In Tunisia, the prescription of insulin analogs is increasingly « automatic » by practicians, convinced by this treatment superiority over human insulin in diabetes management. The aim of our study is to determine whether the analogs prescription modalities and advantages are known by the patients, and to assess the factors associated with this knowledge.Patient and Methods: We conducted a retrospective study including 65 diabetic...

ea0081ep709 | Pituitary and Neuroendocrinology | ECE2022

A rare association of Neurofibromatosis type 2 and hypopituitarism

Ghram Lina , Gharbi Radhouen , Essayeh Sawsen , KANDARA Hajer , Jemel Manel , KAMMOUN Ines

Introduction: Neurofibromatosis type 2 (NF2) is an autosomal dominant genetic disorder that cause a growth of noncancerous tumors in the nervous system, it associates cranial schwannomas, meningiomas, and skin and ophthalmologic lesions. It is a rare condition and its association with an intrasellar arachnoidocele has not been reported yet. We report the case of a patient who presents a NF2 associated with hypopituitarism related to an intrasellar arachnoidocele.<p class="...

ea0081ep956 | Thyroid | ECE2022

Dosing study of brand vs. generic levothyroxine in well-controlled primary hypothyroidism

Kamoun Elyes , Jemel Manel , Gharbi Radhouen , Mkaouer Samir , Kandara Hajer , Kammoun Ines

Introduction: Most brand-name drugs do not differ that much from their generic counterparts, so switching between the two is not an issue. Levothyroxine, however, is an exception. The question of generic equivalency of levothyroxine products has remained unanswered for several decades. The purpose of the present study was to learn whether there is a difference of dosage between brand-name and generic levothyroxine in patient with well controlled primary hypothyroidism<p cl...

ea0081ep957 | Thyroid | ECE2022

Did well-controlled hypothyroid patients have necessary good compliance?

Kamoun Elyes , Jemel Manel , Gharbi Radhouen , Hilel Wafa Ben , Kandara Hajer , Kammoun Ines

Introduction: Treatment of primary hypothyroidism relies on a daily intake of levothyroxine, which dosage is determined first by the weight then by TSH levels monitoring. The daily dosage can vary with the cause of the hypothyroidism and the weight. The aim of our study was to determine if the adherence was a factor influencing the dosage of levothyroxine in a group of well-controlled hypothyroid patients.Method: We performed a cross-sectional study incl...

ea0090p525 | Thyroid | ECE2023

A rare association of hyperthyroidism with Darier disease: case report

Ben Yamna Hadami , Chiboub Marwa , Had Khadija , Gharbi Radhouen , Kandara Hajer , Kammoun Ines

Introduction: Darier disease, also known as dyskeratosis follicularis, is a rare autosomal dominant genodermatosis characterized by a persistent eruption of keratotic papules. It is caused by mutations in the ATP2A2 gene encoding sarcoendoplasmic reticulum Ca 2+ -ATPase isoform 2 in the endoplasmic reticulum. Since it is expressed in most tissues, other organs besides the skin may be involved in Darier disease. In this case, we report a patient treated for Darier disease who w...